• Home
  • News
2022-10-13 | views:1539
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx
2022-10-13 | views:1774
Research Collaboration between Prof. Antonio Gasbarrini team at Gemelli Hospital and Asian Biotech companies, Coree and Dx&Vx
2022-10-12 | views:828
"고령 암환자도 면역항암제 치료 적극 고려해야"
2022-10-07 | views:866
디엑스앤브이엑스, 170억원 규모 추가 투자유치 성공
2022-10-06 | views:739
KAIST, 염증성 장질환 진단 및 회복의 핵심효소 발견
2022-09-26 | views:899
차세대백신 게임체인저 ‘mRNA’ 확보 나선다
2022-09-20 | views:744
심장질환과 알츠하이머 치매 연관 유전자 입증
2022-09-20 | views:952
디엑스앤브이엑스, 한국바이오팜 대표에 유건상 부사장 선임
2022-09-16 | views:916
디엑스앤브이엑스, 한국바이오팜 150억에 인수 계약… “GMP 확보로 CDMO 시장 진출”
  1.   
  2. 29
  3. 30
  4. 31
  5. 32
  6. 33
  7. 34
  8. 35
  9.   
  • 10F, 173, Digital-ro, Geumcheon-gu, Seoul (Gasan-dong, Elysian)
  • Tel : 02-890-8700
  • IR Service : 02-6964-8770
  • Fax : 02-6964-8755

About Us

Goals & Promise

Leadership

Company History

IR

Notice & IR

Disclosure Information

Dx&Vx 2023 Award Impact

Contact

Private Policy Terms of Use twitter icon @dxvx_official
© 2024 Dx&Vx. All Rights Reserved.